Carcinoembryonic Antigen Market Size By Application (Gastrointestinal Cancer [Colon Cancer, Pancreatic Cancer, Rectal Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, Gallbladder Cancer, Anal Cancer], Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Thyroid Cancer), By Gender (Male, Female), By End-user (Hospitals, Diagnostic Centers, Cancer Centers, Research and Academic Institutes) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Jan 2019  |  Report ID: GMI427  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 280   |   Base Year: 2017




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.     Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1.   Paid sources

1.4.1.2.         Unpaid sources

1.4.2. Primary

Chapter 2.     Executive Summary

2.1. Carcinoembryonic antigen industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Application trends

2.1.3.  Gender trends

2.1.4.  End-user trends

2.1.5.  Regional trends   

Chapter 3.     Carcinoembryonic Antigen Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Rise in cancer prevalence

3.3.1.2.  Growing demand for minimally invasive diagnostic procedures

3.3.1.3.  Recent technological advancements in carcinoembryonic antigen diagnostics     

3.3.1.4.  Increasing per capita healthcare expenditure

3.3.2.  Industry pitfalls & challenges

3.3.2.1.  Inability to detect early stage cancer

3.3.2.2.  Lack of awareness regarding the application of carcinoembryonic antigen tests

3.4. Growth potential analysis

3.4.1.  By application

3.4.2.  By gender

3.4.3.  By end-user

3.5. Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6. Global prevalence of top cancers, by region, 2018

3.6.1.  North America

3.6.1.1.    U.S.

3.6.1.2.    Canada

3.6.2.  Europe

3.6.2.1.    Germany

3.6.2.2.    UK

3.6.2.3.    France

3.6.2.4.    Spain

3.6.2.5.    Italy

3.6.2.6.    Poland

3.6.2.7.    Russia

3.6.2.8.    Sweden

3.6.2.9.    Switzerland

3.6.2.10.  Netherlands

3.6.3.  Asia Pacific

3.6.3.1.    China

3.6.3.2.    Japan

3.6.3.3.    India

3.6.3.4.    Australia

3.6.3.5.    South Korea

3.6.3.6.    New Zealand

3.6.3.7.    Malaysia

3.6.3.8.    Singapore

3.6.3.9.    Indonesia

3.6.3.10.  Philippines

3.6.4.  Latin America

3.6.4.1.    Brazil

3.6.4.2.    Mexico

3.6.4.3.    Argentina

3.6.4.4.    Columbia

3.6.4.5.    Peru

3.6.5.  Middle East and Africa

3.6.5.1.    South Africa

3.6.5.2.    Saudi Arabia

3.6.5.3.    UAE

3.7. Porter’s analysis

3.8. Competitive landscape, 2017

3.8.1.   Business overview

3.8.2.  Revenue analysis

3.8.3.  Product landscape

3.8.4.  Strategy dashboard

3.9. PESTEL analysis

Chapter 4.     Carcinoembryonic Antigen Market, By Application

4.1. Global carcinoembryonic antigen market share, by application, 2017 & 2024

4.2. Gastrointestinal Cancer

4.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.2.  Colon Cancer

4.2.2.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.3.  Pancreatic Cancer

4.2.3.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.4.  Rectal Cancer

4.2.4.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.5.  Liver Cancer

4.2.5.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.6.  Stomach Cancer

4.2.6.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.7.  Esophageal Cancer

4.2.7.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.8.  Gallbladder Cancer

4.2.8.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.9.  Anal Cancer

4.2.9.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.3. Breast Cancer

4.3.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.4. Lung Cancer

4.4.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.5. Ovarian Cancer

4.5.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.6. Prostate Cancer

4.6.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.7. Thyroid Cancer

4.7.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

Chapter 5.     Carcinoembryonic Antigen Market, By Gender

5.1. Global carcinoembryonic antigen market share, by gender, 2017 & 2024

5.2. Male

5.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

5.3. Female

5.3.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

Chapter 6.     Carcinoembryonic Antigen Market, By End-user

6.1. Global carcinoembryonic antigen market share, by end-user, 2017 & 2024

6.2. Hospitals

6.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

6.3. Diagnostic Centers

6.3.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

6.4. Cancer Centers

6.4.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

6.5. Research and Academic Institutes

6.5.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

6.6. Others

6.6.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

Chapter 7.     Carcinoembryonic Antigen Market, By Region

7.1. Carcinoembryonic antigen market share, by region, 2017 & 2024

7.2. North America

7.2.1.    Market estimates and forecast, by country, 2013 – 2024

7.2.2.    Market estimates and forecast, by application, 2013 – 2024

7.2.2.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.2.3.    Market estimates and forecast, by gender, 2013 – 2024

7.2.4.    Market estimates and forecast, by end-user, 2013 – 2024

7.2.5.    U.S.

7.2.5.1.    Market estimates and forecast, by application, 2013 – 2024

7.2.5.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.2.5.2.    Market estimates and forecast, by gender, 2013 – 2024

7.2.5.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.2.6.    Canada

7.2.6.1.    Market estimates and forecast, by application, 2013 – 2024

7.2.6.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.2.6.2.    Market estimates and forecast, by gender, 2013 – 2024

7.2.6.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3. Europe

7.3.1.    Market estimates and forecast, by country, 2013 – 2024

7.3.2.    Market estimates and forecast, by application, 2013 – 2024

7.3.2.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.3.    Market estimates and forecast, by gender, 2013 – 2024

7.3.4.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.5.    Germany

7.3.5.1.    Market estimates and forecast, by application, 2013 – 2024

7.3.5.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.5.2.    Market estimates and forecast, by gender, 2013 – 2024

7.3.5.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.6.    UK

7.3.6.1.    Market estimates and forecast, by application, 2013 – 2024

7.3.6.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.6.2.    Market estimates and forecast, by gender, 2013 – 2024

7.3.6.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.7.    France

7.3.7.1.    Market estimates and forecast, by application, 2013 – 2024

7.3.7.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.7.2.    Market estimates and forecast, by gender, 2013 – 2024

7.3.7.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.8.    Spain

7.3.8.1.    Market estimates and forecast, by application, 2013 – 2024

7.3.8.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.8.2.    Market estimates and forecast, by gender, 2013 – 2024

7.3.8.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.9.    Italy

7.3.9.1.    Market estimates and forecast, by application, 2013 – 2024

7.3.9.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.9.2.    Market estimates and forecast, by gender, 2013 – 2024

7.3.9.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.3.10.   Poland

7.3.10.1.  Market estimates and forecast, by application, 2013 – 2024

7.3.10.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.10.2.  Market estimates and forecast, by gender, 2013 – 2024

7.3.10.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.3.11.   Russia

7.3.11.1.  Market estimates and forecast, by application, 2013 – 2024

7.3.11.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.11.2.  Market estimates and forecast, by gender, 2013 – 2024

7.3.11.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.3.12.   Sweden

7.3.12.1.  Market estimates and forecast, by application, 2013 – 2024

7.3.12.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.12.2.  Market estimates and forecast, by gender, 2013 – 2024

7.3.12.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.3.13.   Switzerland

7.3.13.1.  Market estimates and forecast, by application, 2013 – 2024

7.3.13.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.13.2.  Market estimates and forecast, by gender, 2013 – 2024

7.3.13.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.3.14.   Netherlands

7.3.14.1.  Market estimates and forecast, by application, 2013 – 2024

7.3.14.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.3.14.2.  Market estimates and forecast, by gender, 2013 – 2024

7.3.14.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.4. Asia Pacific

7.4.1.    Market estimates and forecast, by country, 2013 – 2024

7.4.2.    Market estimates and forecast, by application, 2013 – 2024

7.4.2.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.3.    Market estimates and forecast, by gender, 2013 – 2024

7.4.4.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.5.    China

7.4.5.1.    Market estimates and forecast, by application, 2013 – 2024

7.4.5.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.5.2.    Market estimates and forecast, by gender, 2013 – 2024

7.4.5.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.6.    Japan

7.4.6.1.    Market estimates and forecast, by application, 2013 – 2024

7.4.6.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.6.2.    Market estimates and forecast, by gender, 2013 – 2024

7.4.6.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.7.    India

7.4.7.1.    Market estimates and forecast, by application, 2013 – 2024

7.4.7.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.7.2.    Market estimates and forecast, by gender, 2013 – 2024

7.4.7.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.8.    Australia

7.4.8.1.    Market estimates and forecast, by application, 2013 – 2024

7.4.8.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.8.2.    Market estimates and forecast, by gender, 2013 – 2024

7.4.8.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.9.    South Korea

7.4.9.1.    Market estimates and forecast, by application, 2013 – 2024

7.4.9.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.9.2.    Market estimates and forecast, by gender, 2013 – 2024

7.4.9.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.4.10.   New Zealand

7.4.10.1.  Market estimates and forecast, by application, 2013 – 2024

7.4.10.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.10.2.  Market estimates and forecast, by gender, 2013 – 2024

7.4.10.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.4.11.   Malaysia

7.4.11.1.  Market estimates and forecast, by application, 2013 – 2024

7.4.11.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.11.2.  Market estimates and forecast, by gender, 2013 – 2024

7.4.11.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.4.12.   Singapore

7.4.12.1.  Market estimates and forecast, by application, 2013 – 2024

7.4.12.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.12.2.  Market estimates and forecast, by gender, 2013 – 2024

7.4.12.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.4.13.   Indonesia

7.4.13.1.  Market estimates and forecast, by application, 2013 – 2024

7.4.13.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.13.2.  Market estimates and forecast, by gender, 2013 – 2024

7.4.13.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.4.14.   Philippines

7.4.14.1.  Market estimates and forecast, by application, 2013 – 2024

7.4.14.1.1.  Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.4.14.2.  Market estimates and forecast, by gender, 2013 – 2024

7.4.14.3.  Market estimates and forecast, by end-user, 2013 – 2024

7.5. Latin America

7.5.1.    Market estimates and forecast, by country, 2013 – 2024

7.5.2.    Market estimates and forecast, by application, 2013 – 2024

7.5.2.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.3.    Market estimates and forecast, by gender, 2013 – 2024

7.5.4.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.5.    Brazil

7.5.5.1.    Market estimates and forecast, by application, 2013 – 2024

7.5.5.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.5.2.    Market estimates and forecast, by gender, 2013 – 2024

7.5.5.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.6.    Mexico

7.5.6.1.    Market estimates and forecast, by application, 2013 – 2024

7.5.6.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.6.2.    Market estimates and forecast, by gender, 2013 – 2024

7.5.6.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.7.    Argentina

7.5.7.1.    Market estimates and forecast, by application, 2013 – 2024

7.5.7.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.7.2.    Market estimates and forecast, by gender, 2013 – 2024

7.5.7.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.8.    Columbia

7.5.8.1.    Market estimates and forecast, by application, 2013 – 2024

7.5.8.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.8.2.    Market estimates and forecast, by gender, 2013 – 2024

7.5.8.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.9.    Peru

7.5.9.1.    Market estimates and forecast, by application, 2013 – 2024

7.5.9.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.5.9.2.    Market estimates and forecast, by gender, 2013 – 2024

7.5.9.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.5.9.4.    Market estimates and forecast, by age group, 2013 – 2024

7.6. Middle East & Africa

7.6.1.    Market estimates and forecast, by country, 2013 – 2024

7.6.2.    Market estimates and forecast, by application, 2013 – 2024

7.6.2.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.6.3.    Market estimates and forecast, by gender, 2013 – 2024

7.6.4.    Market estimates and forecast, by end-user, 2013 – 2024

7.6.5.    South Africa

7.6.5.1.    Market estimates and forecast, by application, 2013 – 2024

7.6.5.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.6.5.2.    Market estimates and forecast, by gender, 2013 – 2024

7.6.5.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.6.6.    Saudi Arabia

7.6.6.1.    Market estimates and forecast, by application, 2013 – 2024

7.6.6.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.6.6.2.    Market estimates and forecast, by gender, 2013 – 2024

7.6.6.3.    Market estimates and forecast, by end-user, 2013 – 2024

7.6.7.    UAE

7.6.7.1.    Market estimates and forecast, by application, 2013 – 2024

7.6.7.1.1.    Market estimates and forecast, by gastrointestinal cancer, 2013 – 2024

7.6.7.2.    Market estimates and forecast, by gender, 2013 – 2024

7.6.7.3.    Market estimates and forecast, by end-user, 2013 – 2024

Chapter 8.     Company Profiles

8.1.   F. Hoffmann-La Roche Ltd

8.1.1.   Business overview

8.1.2.   Financial data

8.1.3.   Product landscape

8.1.4.   Strategic outlook

8.1.5.   SWOT analysis

8.2.   Quest Diagnostics

8.2.1.   Business overview

8.2.2.   Financial data

8.2.3.   Product landscape

8.2.4.   Strategic outlook

8.2.5.   SWOT analysis

8.3.   GenWay Biotech Inc.

8.3.1.   Business overview

8.3.2.   Financial data

8.3.3.   Product landscape

8.3.4.   Strategic outlook

8.3.5.   SWOT analysis

8.4.   Correlogic Systems, Inc.

8.4.1.   Business overview

8.4.2.   Financial data

8.4.3.   Product landscape

8.4.4.   Strategic outlook

8.4.5.   SWOT analysis

8.5.   Creative Diagnostics

8.5.1.   Business overview

8.5.2.   Financial data

8.5.3.   Product landscape

8.5.4.   Strategic outlook

8.5.5.   SWOT analysis

8.6.   Omega Diagnostics Group PLC

8.6.1.   Business overview

8.6.2.   Financial data

8.6.3.   Product landscape

8.6.4.   Strategic outlook

8.6.5.   SWOT analysis

8.7.   RayBiotech, Inc.

8.7.1.   Business overview

8.7.2.   Financial data

8.7.3.   Product landscape

8.7.4.   Strategic outlook

8.7.5.   SWOT analysis

8.8. Boster Biological Technology

8.8.1.   Business overview

8.8.2.   Financial data

8.8.3.   Product landscape

8.8.4.   Strategic outlook

8.8.5.   SWOT analysis

 

Data Tables

TABLE 1.    Carcinoembryonic antigen industry 3600 synopsis, 2013 – 2024

TABLE 2.    Global carcinoembryonic antigen market, 2013 – 2017 (USD Million)

TABLE 3.    Global carcinoembryonic antigen market, 2018 – 2024 (USD Million)

TABLE 4.    Global carcinoembryonic antigen market, by application, 2013 – 2017 (USD Million)

TABLE 5.    Global carcinoembryonic antigen market, by application, 2018 – 2024 (USD Million)

TABLE 6.    Global carcinoembryonic antigen market, by gender, 2013 – 2017 (USD Million)

TABLE 7.    Global carcinoembryonic antigen market, by gender, 2018 – 2024 (USD Million)

TABLE 8.    Global carcinoembryonic antigen market, by end-user, 2013 – 2017 (USD Million)

TABLE 9.    Global carcinoembryonic antigen market, by type, 2018 – 2024 (USD Million)

TABLE 10.   Global carcinoembryonic antigen market, by region, 2013 – 2017 (USD Million)

TABLE 11.   Global carcinoembryonic antigen market, by region, 2018 – 2024 (USD Million)

TABLE 12.   Industry impact forces

TABLE 13.   U.S. cancer prevalence, 2018

TABLE 14.   Canada cancer prevalence, 2018

TABLE 15.   Germany cancer prevalence, 2018

TABLE 16.   UK cancer prevalence, 2018

TABLE 17.   France cancer prevalence, 2018

TABLE 18.   Spain cancer prevalence, 2018

TABLE 19.   Italy cancer prevalence, 2018

TABLE 20.   Poland cancer prevalence, 2018

TABLE 21.   Russia cancer prevalence, 2018

TABLE 22.   Sweden cancer prevalence, 2018

TABLE 23.   Switzerland cancer prevalence, 2018

TABLE 24.   The Netherlands cancer prevalence, 2018

TABLE 25.   China cancer prevalence, 2018

TABLE 26.   Japan cancer prevalence, 2018

TABLE 27.   India cancer prevalence, 2018

TABLE 28.   Australia cancer prevalence, 2018

TABLE 29.   South Korea cancer prevalence, 2018

TABLE 30.   New Zealand cancer prevalence, 2018

TABLE 31.   Singapore cancer prevalence, 2018

TABLE 32.   Singapore cancer prevalence, 2018

TABLE 33.   Indonesia cancer prevalence, 2018

TABLE 34.   Philippines cancer prevalence, 2018

TABLE 35.   Brazil cancer prevalence, 2018

TABLE 36.   Mexico cancer prevalence, 2018

TABLE 37.   Argentina cancer prevalence, 2018

TABLE 38.   Columbia cancer prevalence, 2018

TABLE 39.   Peru cancer prevalence, 2018

TABLE 40.   South Africa cancer prevalence, 2018

TABLE 41.   Saudi Arabia cancer prevalence, 2018

TABLE 42.   UAE cancer prevalence, 2018

TABLE 43.   Gastrointestinal cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 44.   Gastrointestinal cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 45.   Colon cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 46.   Colon cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 47.   Pancreatic cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 48.   Pancreatic cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 49.   Rectal cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 50.   Rectal cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 51.   Liver cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 52.   Liver cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 53.   Stomach cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 54.   Stomach cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 55.   Esophageal cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 56.   Esophageal cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 57.   Gallbladder cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 58.   Gallbladder cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 59.   Anal cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 60.   Anal cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 61.   Breast cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 62.   Breast cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 63.   Lung cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 64.   Lung cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 65.   Ovarian cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 66.   Ovarian cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 67.   Prostate cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 68.   Prostate cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 69.   Thyroid cancer market size, by region, 2013 – 2024 (USD Million)

TABLE 70.   Thyroid cancer market size, by region, 2018 – 2024 (USD Million)

TABLE 71.   Male market size, by region, 2013 – 2024 (USD Million)

TABLE 72.   Male market size, by region, 2018 – 2024 (USD Million)

TABLE 73.   Female market size, by region, 2013 – 2024 (USD Million)

TABLE 74.   Female market size, by region, 2018 – 2024 (USD Million)

TABLE 75.   Hospitals market size, by region, 2013 – 2024 (USD Million)

TABLE 76.   Hospitals market size, by region, 2018 – 2024 (USD Million)

TABLE 77.   Diagnostic centers market size, by region, 2013 – 2024 (USD Million)

TABLE 78.   Diagnostic centers market size, by region, 2018 – 2024 (USD Million)

TABLE 79.   Cancer centers market size, by region, 2013 – 2024 (USD Million)

TABLE 80.   Cancer centers market size, by region, 2018 – 2024 (USD Million)

TABLE 81.   Research and academic institutes market size, by region, 2013 – 2024 (USD Million)

TABLE 82.   Research and academic institutes market size, by region, 2018 – 2024 (USD Million)

TABLE 83.   Others market size, by region, 2013 – 2024 (USD Million)

TABLE 84.   Others market size, by region, 2018 – 2024 (USD Million)

TABLE 85.   North America carcinoembryonic antigen market size, by country, 2013 - 2024 (USD Million)

TABLE 86.   North America carcinoembryonic antigen market size, by country, 2018 – 2024 (USD Million)

TABLE 87.   North America carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 88.   North America carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 89.   North America carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 90.   North America carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 91.   North America carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 92.   North America carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 93.   North America carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 94.   North America carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 95.   U.S. carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 96.   U.S. carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 97.   U.S. carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 98.   U.S. carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 99.   U.S. carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 100.  U.S. carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 101.  U.S. carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 102.  U.S. carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 103.  Canada carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 104.  Canada carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 105.  Canada carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 106.  Canada carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 107.  Canada carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 108.  Canada carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 109.  Canada carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 110.  Canada carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 111.  Europe carcinoembryonic antigen market size, by country, 2013 - 2024 (USD Million)

TABLE 112.  Europe carcinoembryonic antigen market size, by country, 2018 – 2024 (USD Million)

TABLE 113.  Europe carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 114.  Europe carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 115.  Europe carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 116.  Europe carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 117.  Europe carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 118.  Europe carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 119.  Europe carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 120.  Europe carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 121.  Germany carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 122.  Germany carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 123.  Germany carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 124.  Germany carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 125.  Germany carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 126.  Germany carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 127.  Germany carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 128.  Germany carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 129.  UK carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 130.  UK carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 131.  UK carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 132.  UK carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 133.  UK carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 134.  UK carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 135.  UK carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 136.  UK carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 137.  France carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 138.  France carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 139.  France carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 140.  France carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 141.  France carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 142.  France carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 143.  France carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 144.  France carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 145.  Spain carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 146.  Spain carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 147.  Spain carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 148.  Spain carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 149.  Spain carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 150.  Spain carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 151.  Spain carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 152.  Spain carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 153.  Italy carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 154.  Italy carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 155.  Italy carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 156.  Italy carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 157.  Italy carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 158.  Italy carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 159.  Italy carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 160.  Italy carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 161.  Poland carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 162.  Poland carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 163.  Poland carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 164.  Poland carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 165.  Poland carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 166.  Poland carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 167.  Poland carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 168.  Poland carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 169.  Russia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 170.  Russia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 171.  Russia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 172.  Russia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 173.  Russia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 174.  Russia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 175.  Russia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 176.  Russia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 177.  Sweden carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 178.  Sweden carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 179.  Sweden carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 180.  Sweden carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 181.  Sweden carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 182.  Sweden carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 183.  Sweden carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 184.  Sweden carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 185.  Switzerland carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 186.  Switzerland carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 187.  Switzerland carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 188.  Switzerland carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 189.  Switzerland carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 190.  Switzerland carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 191.  Switzerland carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 192.  Switzerland carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 193.  The Netherlands carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 194.  The Netherlands carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 195.  The Netherlands carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 196.  The Netherlands carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 197.  The Netherlands carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 198.  The Netherlands carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 199.  The Netherlands carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 200.  The Netherlands carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 201.  Asia Pacific carcinoembryonic antigen market size, by country, 2013 - 2024 (USD Million)

TABLE 202.  Asia Pacific carcinoembryonic antigen market size, by country, 2018 – 2024 (USD Million)

TABLE 203.  Asia Pacific carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 204.  Asia Pacific carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 205.  Asia Pacific carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 206.  Asia Pacific carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 207.  Asia Pacific carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 208.  Asia Pacific carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 209.  Asia Pacific carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 210.  Asia Pacific carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 211.  China carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 212.  China carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 213.  China carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 214.  China carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 215.  China carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 216.  China carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 217.  China carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 218.  China carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 219.  Japan carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 220.  Japan carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 221.  Japan carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 222.  Japan carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 223.  Japan carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 224.  Japan carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 225.  Japan carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 226.  Japan carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 227.  India carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 228.  India carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 229.  India carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 230.  India carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 231.  India carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 232.  India carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 233.  India carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 234.  India carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 235.  Australia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 236.  Australia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 237.  Australia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 238.  Australia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 239.  Australia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 240.  Australia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 241.  Australia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 242.  Australia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 243.  South Korea carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 244.  South Korea carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 245.  South Korea carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 246.  South Korea carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 247.  South Korea carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 248.  South Korea carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 249.  South Korea carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 250.  South Korea carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 251.  New Zealand carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 252.  New Zealand carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 253.  New Zealand carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 254.  New Zealand carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 255.  New Zealand carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 256.  New Zealand carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 257.  New Zealand carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 258.  New Zealand carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 259.  Malaysia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 260.  Malaysia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 261.  Malaysia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 262.  Malaysia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 263.  Malaysia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 264.  Malaysia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 265.  Malaysia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 266.  Malaysia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 267.  Singapore carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 268.  Singapore carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 269.  Singapore carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 270.  Singapore carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 271.  Singapore carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 272.  Singapore carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 273.  Singapore carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 274.  Singapore carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 275.  Indonesia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 276.  Indonesia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 277.  Indonesia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 278.  Indonesia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 279.  Indonesia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 280.  Indonesia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 281.  Indonesia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 282.  Indonesia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 283.  Philippines carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 284.  Philippines carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 285.  Philippines carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 286.  Philippines carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 287.  Philippines carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 288.  Philippines carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 289.  Philippines carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 290.  Philippines carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 291.  Latin America carcinoembryonic antigen market size, by country, 2013 - 2024 (USD Million)

TABLE 292.  Latin America carcinoembryonic antigen market size, by country, 2018 – 2024 (USD Million)

TABLE 293.  Latin America carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 294.  Latin America carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 295.  Latin America carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 296.  Latin America carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 297.  Latin America carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 298.  Latin America carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 299.  Latin America carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 300.  Latin America carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 301.  Brazil carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 302.  Brazil carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 303.  Brazil carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 304.  Brazil carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 305.  Brazil carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 306.  Brazil carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 307.  Brazil carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 308.  Brazil carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 309.  Mexico carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 310.  Mexico carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 311.  Mexico carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 312.  Mexico carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 313.  Mexico carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 314.  Mexico carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 315.  Mexico carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 316.  Mexico carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 317.  Argentina carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 318.  Argentina carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 319.  Argentina carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 320.  Argentina carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 321.  Argentina carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 322.  Argentina carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 323.  Argentina carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 324.  Argentina carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 325.  Columbia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 326.  Columbia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 327.  Columbia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 328.  Columbia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 329.  Columbia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 330.  Columbia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 331.  Columbia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 332.  Columbia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 333.  Peru carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 334.  Peru carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 335.  Peru carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 336.  Peru carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 337.  Peru carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 338.  Peru carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 339.  Peru carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 340.  Peru carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 341.  MEA carcinoembryonic antigen market size, by country, 2013 - 2024 (USD Million)

TABLE 342.  MEA carcinoembryonic antigen market size, by country, 2018 – 2024 (USD Million)

TABLE 343.  MEA carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 344.  MEA carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 345.  MEA carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 346.  MEA carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 347.  MEA carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 348.  MEA carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 349.  MEA carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 350.  MEA carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 351.  South Africa carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 352.  South Africa carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 353.  South Africa carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 354.  South Africa carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 355.  South Africa carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 356.  South Africa carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 357.  South Africa carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 358.  South Africa carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 359.  Saudi Arabia carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 360.  Saudi Arabia carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 361.  Saudi Arabia carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 362.  Saudi Arabia carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 363.  Saudi Arabia carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 364.  Saudi Arabia carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 365.  Saudi Arabia carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 366.  Saudi Arabia carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

TABLE 367.  UAE carcinoembryonic antigen market size, by application, 2013 - 2027 (USD Million)

TABLE 368.  UAE carcinoembryonic antigen market size, by application, 2018 - 2024 (USD Million)

TABLE 369.  UAE carcinoembryonic antigen market size, by gastrointestinal cancer, 2013 - 2027 (USD Million)

TABLE 370.  UAE carcinoembryonic antigen market size, by gastrointestinal cancer, 2018 - 2024 (USD Million)

TABLE 371.  UAE carcinoembryonic antigen market size, by gender, 2013 - 2027 (USD Million)

TABLE 372.  UAE carcinoembryonic antigen market size, by gender, 2018 - 2024 (USD Million)

TABLE 373.  UAE carcinoembryonic antigen market size, by end-user, 2013 - 2027 (USD Million)

TABLE 374.  UAE carcinoembryonic antigen market size, by end-user, 2018 - 2024 (USD Million)

 

Charts & Figures

FIG. 1 Industry segmentation

FIG. 2 Global carcinoembryonic antigen market, 2013 – 2024 (USD Million)

FIG. 3 Growth potential analysis, by application

FIG. 4 Growth potential analysis, by gender

FIG. 5 Growth potential analysis, by end-user

FIG. 6 Global prevalence of top cancer, 2018

FIG. 7 U.S. cancer prevalence, 2018

FIG. 8 Canada cancer prevalence, 2018

FIG. 9 Germany cancer prevalence, 2018

FIG. 10  UK cancer prevalence, 2018

FIG. 11  France cancer prevalence, 2018

FIG. 12  Spain cancer prevalence, 2018

FIG. 13  Italy cancer prevalence, 2018

FIG. 14  Poland cancer prevalence, 2018

FIG. 15  Russia cancer prevalence, 2018

FIG. 16  Sweden cancer prevalence, 2018

FIG. 17  Switzerland cancer prevalence, 2018

FIG. 18  The Netherland cancer prevalence, 2018

FIG. 19  China cancer prevalence, 2018

FIG. 20  Japan cancer prevalence, 2018

FIG. 21  India cancer prevalence, 2018

FIG. 22  Australia cancer prevalence, 2018

FIG. 23  South Korea cancer prevalence, 2018

FIG. 24  New Zealand cancer prevalence, 2018

FIG. 25  Malaysia cancer prevalence, 2018

FIG. 26  Singapore cancer prevalence, 2018

FIG. 27  Indonesia cancer prevalence, 2018

FIG. 28  Philippines cancer prevalence, 2018

FIG. 29  Brazil cancer prevalence, 2018

FIG. 30  Mexico cancer prevalence, 2018

FIG. 31  Argentina cancer prevalence, 2018

FIG. 32  Columbia cancer prevalence, 2018

FIG. 33  Peru cancer prevalence, 2018

FIG. 34  South Africa cancer prevalence, 2018

FIG. 35  Saudi Arabia cancer prevalence, 2018

FIG. 36  UAE cancer prevalence, 2018

FIG. 37  Porter’s analysis

FIG. 38  PESTEL analysis

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jan 2019
  • Pages: 280
  • Tables: 374
  • Charts / Figures: 38
  • Companies covered: 8
  • Countries covered: 30

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X